These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 68071)

  • 1. Neutralization kinetics studies with type SAT 2 foot-and-mouth disease virus strains.
    Rweyemamu MM; Booth JC; Parry N; Pay TW
    J Hyg (Lond); 1977 Jun; 78(3):429-38. PubMed ID: 68071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of vaccine strains of foot and mouth disease virus for use in southern Africa.
    Fargeaud D
    Rev Sci Tech; 1995 Sep; 14(3):521-38. PubMed ID: 8593387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological differentiation of foot-and-mouth disease virus strains in relation to selection of suitable vaccine viruses.
    Rweyemamu MM; Pay TW; Parker MJ
    Dev Biol Stand; 1976; 35():205-4. PubMed ID: 198288
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of some immunological methods for the differentiation of strains of foot-and-mouth disease virus.
    Forman AJ
    J Hyg (Lond); 1975 Apr; 74(2):215-25. PubMed ID: 164500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilizing the immunizing antigen of foot-and-mouth disease virus by fixation with formaldehyde.
    Rowlands DJ; Sangar DV; Brown F
    Arch Gesamte Virusforsch; 1972; 39(1):274-83. PubMed ID: 4344146
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction.
    Rweyemamu MM
    J Biol Stand; 1984 Jul; 12(3):323-37. PubMed ID: 6207176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the Relationship between immunity and the level of neutralizing antibodies in pigs vaccinated against foot-and-mouth disease (author's transl)].
    Bauer K; Lorenz RJ; Wittmann G
    Arch Virol; 1975; 49(4):349-57. PubMed ID: 174529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological comparison of a type sat 2 foot-and-mouth disease virus isolate from Sudan with other type SAT 2 strains.
    Abu Elzein EM; Crowther JR
    Bull Anim Health Prod Afr; 1979 Dec; 27(4):245-8. PubMed ID: 232850
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus.
    Kitching RP; Rendle R; Ferris NP
    Vaccine; 1988 Oct; 6(5):403-8. PubMed ID: 2848376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains.
    Rweyemamu MM; Booth JC; Head M; Pay TW
    J Hyg (Lond); 1978 Aug; 81(1):107-23. PubMed ID: 211160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus.
    Doel TR; Chong WK
    Arch Virol; 1982; 73(2):185-91. PubMed ID: 6293410
    [No Abstract]   [Full Text] [Related]  

  • 12. The challenge of vaccinated pigs with foot-and-mouth disease virus.
    de Leeuw PW; Tiessink JW; van Bekkum JG
    Zentralbl Veterinarmed B; 1979 Mar; 26(2):98-109. PubMed ID: 231356
    [No Abstract]   [Full Text] [Related]  

  • 13. Escape mutants of foot-and-mouth disease virus selected by monoclonal antibodies directed to a trypsin-sensitive neutralization epitope.
    Das BR; Pattnaik B; Venkataramanan R; Rai DV
    Acta Virol; 1997 Jun; 41(3):131-8. PubMed ID: 9385400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the antigenic variation within type-A foot and mouth disease virus isolates from Asia.
    Rweyemamu MM; Ouldridge EJ; Head M; Purse F
    J Biol Stand; 1984; 12(2):191-4. PubMed ID: 6203914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Testing of the activity of anti-foot-and-mouth disease vaccines].
    Fédida M; Dannacher G; Coudert M; Perrin M; Martel JL
    Dev Biol Stand; 1976; 35():243-70. PubMed ID: 198292
    [No Abstract]   [Full Text] [Related]  

  • 17. A serological and biochemical study of new field isolates of foot-and-mouth disease virus type A in Peru, 1975 to 1981.
    Espinoza AM; Knowles NJ
    Vet Microbiol; 1983 Nov; 8(6):555-62. PubMed ID: 6318421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in foot-and-mouth disease virus isolates in Kenya: an examination of field isolates by T1 oligonucleotide fingerprinting.
    Anderson EC; Underwood BO; Brown F; Ngichabe CK
    Vet Microbiol; 1985 Aug; 10(5):409-23. PubMed ID: 2413611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cross reacting isolates of foot & mouth disease virus.
    Venkataramanan R; Mukhopadhyay AK; Rao BU
    Indian J Exp Biol; 1983 Mar; 21(3):137-42. PubMed ID: 6197366
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigenic features of foot-and-mouth disease virus serotype Asia1 as revealed by monoclonal antibodies and neutralization-escape mutants.
    Sanyal A; Venkataramanan R; Pattnaik B
    Virus Res; 1997 Aug; 50(2):107-17. PubMed ID: 9282776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.